Nab-paclitaxel plus gemcitabine in patients with metastatic or recurrent pancreatic cancer: A single institution experience

Authors :: Atsushi Takeno
Takuya Sakamoto
Takeshi Kato
Kohei Murakami
Yoshinori Kagawa
Yasufumi Sato
Masatsugu Okishiro
Shigeyuki Tamura
Atsushi Naito
Yutaka Takeda
Yoshihiro Morimoto
Tomo Ishida
Yoshiaki Ohmura
Yoshiteru Katsura
Chiyomi Egawa
Yasuo Oneda
Ryuichi Kuwahara
Source :: Pancreatology. 16:S64-S65
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Endocrinology, Diabetes and Metabolism
Gastroenterology
Recurrent pancreatic cancer
Gemcitabine
Internal medicine
Medicine
In patient
Single institution
business
Nab-paclitaxel
medicine.drug

Full Text Access

Tools